Northwest Biotherapeutics, Inc. (NWBO)
USD 0.21
(-1.87%)
USD 0.21
(-1.87%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.06 USD | 57.0% |
| 2022 | -0.13 USD | -161.9% |
| 2021 | 0.21 USD | 128.38% |
| 2020 | -0.74 USD | -1670.33% |
| 2019 | -0.04 USD | 48.59% |
| 2018 | -0.08 USD | 72.9% |
| 2017 | -0.30 USD | 58.33% |
| 2016 | -0.72 USD | 51.35% |
| 2015 | -1.48 USD | 35.37% |
| 2014 | -2.29 USD | -14.5% |
| 2013 | -2.00 USD | 65.03% |
| 2012 | -5.72 USD | -2.51% |
| 2011 | -5.58 USD | 14.55% |
| 2010 | -6.53 USD | 22.54% |
| 2009 | -8.43 USD | -0.12% |
| 2008 | -8.42 USD | 39.55% |
| 2007 | -13.93 USD | -122.17% |
| 2006 | -6.27 USD | 94.99% |
| 2005 | -125.07 USD | -16.55% |
| 2004 | -107.31 USD | -46.98% |
| 2003 | -73.01 USD | 59.82% |
| 2002 | -181.71 USD | 81.79% |
| 2001 | -997.97 USD | 32.31% |
| 2000 | -1474.30 USD | -162.8% |
| 1999 | -561.00 USD | -18.86% |
| 1998 | -472.00 USD | -84.38% |
| 1997 | -256.00 USD | -108.13% |
| 1996 | -123.00 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.02 USD | 6.1% |
| 2024 Q2 | -0.01 USD | 1.95% |
| 2023 Q2 | -0.01 USD | -42.86% |
| 2023 FY | - USD | 57.0% |
| 2023 Q1 | -0.01 USD | 73.85% |
| 2023 Q4 | -0.02 USD | 2.38% |
| 2023 Q3 | -0.02 USD | -29.23% |
| 2022 Q4 | -0.03 USD | 25.48% |
| 2022 Q1 | -0.01 USD | -110.57% |
| 2022 FY | - USD | -161.9% |
| 2022 Q3 | -0.05 USD | -57.77% |
| 2022 Q2 | -0.03 USD | -100.0% |
| 2021 Q3 | 0.05 USD | 900.0% |
| 2021 Q4 | 0.14 USD | 169.23% |
| 2021 Q1 | -0.00 USD | 98.56% |
| 2021 Q2 | 0.01 USD | 206.12% |
| 2021 FY | - USD | 128.38% |
| 2020 FY | - USD | -1670.33% |
| 2020 Q3 | -0.26 USD | -212.88% |
| 2020 Q2 | -0.08 USD | -2126.83% |
| 2020 Q1 | 0.00 USD | -62.39% |
| 2020 Q4 | -0.34 USD | -30.77% |
| 2019 Q2 | 0.00 USD | 101.0% |
| 2019 FY | - USD | 48.59% |
| 2019 Q4 | 0.01 USD | 200.93% |
| 2019 Q3 | -0.01 USD | -2800.0% |
| 2019 Q1 | -0.04 USD | -266.97% |
| 2018 FY | - USD | 72.9% |
| 2018 Q1 | -0.06 USD | 29.73% |
| 2018 Q2 | -0.05 USD | 15.04% |
| 2018 Q3 | 0.03 USD | 153.11% |
| 2018 Q4 | -0.01 USD | -139.93% |
| 2017 Q3 | -0.08 USD | -68.09% |
| 2017 FY | - USD | 58.33% |
| 2017 Q4 | -0.09 USD | -4.11% |
| 2017 Q2 | -0.05 USD | 37.0% |
| 2017 Q1 | -0.08 USD | 67.46% |
| 2016 Q3 | -0.25 USD | -78.57% |
| 2016 Q1 | -0.06 USD | 76.85% |
| 2016 Q4 | -0.24 USD | 4.0% |
| 2016 Q2 | -0.14 USD | -124.0% |
| 2016 FY | - USD | 51.35% |
| 2015 Q1 | -0.67 USD | -4.69% |
| 2015 FY | - USD | 35.37% |
| 2015 Q3 | 0.29 USD | 132.95% |
| 2015 Q4 | -0.27 USD | -193.1% |
| 2015 Q2 | -0.88 USD | -31.34% |
| 2014 Q2 | -0.45 USD | 48.86% |
| 2014 Q3 | -0.35 USD | 22.22% |
| 2014 Q4 | -0.64 USD | -82.86% |
| 2014 Q1 | -0.88 USD | -104.65% |
| 2014 FY | - USD | -14.5% |
| 2013 Q3 | -0.65 USD | -62.5% |
| 2013 Q1 | -0.54 USD | 71.28% |
| 2013 FY | - USD | 65.03% |
| 2013 Q4 | -0.43 USD | 33.85% |
| 2013 Q2 | -0.40 USD | 25.93% |
| 2012 Q3 | -1.50 USD | -2300.0% |
| 2012 Q1 | -1.06 USD | 19.08% |
| 2012 FY | - USD | -2.51% |
| 2012 Q4 | -1.88 USD | -25.33% |
| 2012 Q2 | -0.06 USD | 94.1% |
| 2011 Q2 | -2.35 USD | -34.29% |
| 2011 FY | - USD | 14.55% |
| 2011 Q4 | -1.31 USD | -1737.5% |
| 2011 Q3 | 0.08 USD | 103.4% |
| 2011 Q1 | -1.75 USD | 7.89% |
| 2010 Q1 | -1.56 USD | -30.0% |
| 2010 Q2 | -2.19 USD | -40.38% |
| 2010 Q3 | -0.83 USD | 62.1% |
| 2010 FY | - USD | 22.54% |
| 2010 Q4 | -1.90 USD | -128.92% |
| 2009 Q2 | -1.45 USD | 14.2% |
| 2009 Q3 | -4.33 USD | -198.62% |
| 2009 Q4 | -1.20 USD | 72.29% |
| 2009 FY | - USD | -0.12% |
| 2009 Q1 | -1.69 USD | 14.21% |
| 2008 Q3 | -2.04 USD | 10.53% |
| 2008 Q2 | -2.28 USD | -7.04% |
| 2008 Q1 | -2.13 USD | 24.2% |
| 2008 Q4 | -1.97 USD | 3.43% |
| 2008 FY | - USD | 39.55% |
| 2007 Q1 | -7.18 USD | 5.15% |
| 2007 Q3 | -1.48 USD | 90.61% |
| 2007 FY | - USD | -122.17% |
| 2007 Q2 | -15.76 USD | -119.5% |
| 2007 Q4 | -2.81 USD | -89.86% |
| 2006 Q4 | -7.57 USD | -13.83% |
| 2006 Q1 | -49.40 USD | -97.68% |
| 2006 Q3 | -6.65 USD | -127.71% |
| 2006 FY | - USD | 94.99% |
| 2006 Q2 | 24.00 USD | 148.58% |
| 2005 FY | - USD | -16.55% |
| 2005 Q4 | -24.99 USD | 28.6% |
| 2005 Q3 | -35.00 USD | -5.45% |
| 2005 Q2 | -33.19 USD | -4.21% |
| 2005 Q1 | -31.85 USD | 42.49% |
| 2004 FY | - USD | -46.98% |
| 2004 Q4 | -55.38 USD | -93.77% |
| 2004 Q3 | -28.58 USD | -122.41% |
| 2004 Q2 | -12.85 USD | -22.97% |
| 2004 Q1 | -10.45 USD | 5.43% |
| 2003 Q1 | -20.47 USD | 7.92% |
| 2003 FY | - USD | 59.82% |
| 2003 Q4 | -11.05 USD | 26.23% |
| 2003 Q3 | -14.98 USD | 43.79% |
| 2003 Q2 | -26.65 USD | -30.19% |
| 2002 Q3 | -49.73 USD | 21.33% |
| 2002 Q1 | -44.47 USD | 9.32% |
| 2002 FY | - USD | 81.79% |
| 2002 Q4 | -22.23 USD | 55.3% |
| 2002 Q2 | -63.21 USD | -42.14% |
| 2001 Q4 | -49.04 USD | 90.18% |
| 2001 FY | - USD | 32.31% |
| 2001 Q3 | -499.25 USD | 0.0% |
| 2001 Q1 | -499.25 USD | -10.94% |
| 2001 Q2 | -499.25 USD | 0.0% |
| 2000 Q4 | -450.00 USD | -19.68% |
| 2000 FY | - USD | -162.8% |
| 2000 Q3 | -376.00 USD | 0.0% |
| 1999 FY | - USD | -18.86% |
| 1998 FY | - USD | -84.38% |
| 1997 FY | - USD | -108.13% |
| 1996 FY | - USD | 0.0% |